Rheological Determinants in Patients with Gaucher Disease and Internal Inflammation

American Journal of Hematology

Volumn 75, Issue 4, 2004, Pages 190-194

  Zimran, Ari ^a   Bashkin, Amir ^a   Eistein, Deborah ^a   Rudensky, Bernard ^a   Rotstein, Rivka ^b   Rozenblat, Meirav ^b   Mardi, Tamar ^b   Zeltser, David ^b   Deutsch, Varda ^b   Shapira, Itzhak ^b   Berliner, Shlomo ^b,c  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Erythrocyte aggregation; Gaucher disease; Leukocyte aggregation

Indexed keywords

FIBRINOGEN;

ADULT; ARTICLE; BLOOD FLOW; BLOOD RHEOLOGY; CONTROLLED STUDY; ERYTHROCYTE ADHESIVENESS; ERYTHROCYTE AGGREGATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GAUCHER DISEASE; HUMAN; HUMAN CELL; HYPOXEMIA; IMAGE ANALYSIS; INFLAMMATION; LEUKOCYTE ADHERENCE; LEUKOCYTE AGGREGATION; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; PRIORITY JOURNAL;

ADULT; BLOOD SEDIMENTATION; CASE-CONTROL STUDIES; CELL ADHESION; CELL AGGREGATION; COMPLEMENT C3; ERYTHROCYTE AGGREGATION; ERYTHROCYTES; FEMALE; FIBRINOGEN; GAUCHER DISEASE; HEMORHEOLOGY; HUMANS; IMMUNOGLOBULINS; INFLAMMATION; LEUKOCYTES; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC;

EID: 11144354236     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20011     Document Type: Article

References (32)

1. Barak V, Acker M, Nisman B, et al. Cytokines in Gaucher's disease. Eur Cytokine Network 1999;10:205-210.
2. Shoenfeld Y, Gallant LA, Shakarishvilli R, Livni E, Djaldetli M. Pinkhas I. Gaucher's disease: a disease with chronic stimulation of the immune system. Arch Pathol Lab Med 1982;106:388-391.
3. Hollak CE, Evers L, Aerts JM, van Oers MH. Elevated levels of M-CSF, sCD14 and IL8 in type 1 Gaucher disease. Blood Cells Mol Dis 1997;23:201-212.
4. Allen MJ, Myer BJ, Khokher AM, Rushton N, Cox TM. Proinflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10. Q J Med 1997; 90:19-25.
5. Michelakakis H, Spanou C, Kondyli A, et al. Plasma tumor necrosis factor-α (TNF-α) levels in Gaucher disease. Biochim Biophys Acta 1996;1317:219-222.
6. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;11:44-54.
7. Soutani M, Suzuki Y, Tateishi N, Maeda N. Quantitative evaluation of flow dynamics of erythrocytes in microvessels: influence of erythrocyte aggregation. Am J Physiol 1995;268:H1959-H1965.
8. Weng X, Cloutier G, Beaulieu R, Roederer GO. Influence of acute-phase proteins on erythrocyte aggregation. Am J Physiol 1996;271:H2346-H2352.
9. Weng X, Roederer GO, Beaulieu R, Cloutier G. Contribution of acute-phase proteins and cardiovascular risk factors to erythrocyte aggregation in normolipidemic and hyperlipidemic individuals. Thromb Haemost 1998;80:903-908.
10. 2-permeable tube: effects of erythrocyte aggregation. Am J Physiol Heart Circ Physiol 2001;281: H448-H456.
11. International Committee for Standardization in Hematology, Recommendation of measurement of erythrocyte sedimentation rate of human blood. Immunochemistry 1965;2:235-254.
12. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol Basel 1957;17:237-246.
13. Rotstein R, Landau T, Twig A, et al. The erythrocyte adhesiveness/aggregation test (EAAT). A new biomarker to reveal the low-grade subclinical smoldering inflammation individuals with atherosclerotic risk factors. Atherosclerosis 2002;165:343-351.
14. Fusman G, Mardi T, Justo D, et al. Red blood cell adhesiveness/ aggregation. C-reactive protein, fibrinogen and erythrocyte sedimentation rate in healthy adults and in those with atherosclerotic risk factors. Am J Cardiol 2002;90:561-563.
15. Rogowski O, Zeltser D, Rotstein R, et al. Correlated expression of adhesive properties for both white and red blood cells during inflammation, Biorheology 2000;37:361-370.
16. Berliner S, Shapira I, Rogowski O, et al. Combined leukocyte and erythrocyte aggregation in the peripheral venous blood during sepsis. A clue to the presence of a commonly shared adhesive protein(s). Int J Clin Lab Res 2000;30:27-31.
17. Maharshak N, Kassirer M, Zeltser D, et al. The inflammation meter: novel technology to detect the presence of infection/inflammation in patients without leukocylosis but with an increased leukocyte adhesiveness/aggregation. Acta Haematol 2000;104:16-21.
18. Mizukami H, Mi Y, Wada R, et al. Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage. J Clin Invest 2002;2002:1215-1221.
19. Lichtenstein M, Zimran A, Horowitz M. Cytokine mRNA in Gaucher disease. Blood Cells Mol Dis 1997;23:395-401.
20. Imaizumi K, Shiga T. Effect of immunoglobulins and IgG-fragments on the human erythrocyte aggregation, studied by rheoscope combined with image analyzer. Biorheology 1983;20:569-577.
21. Berliner S, Fuchs J, Seligsohn U, et al. Possible role of fibrinogen in the aggregation of white blood cells. Thromb Haemost 1987;58: 749-752.
22. Fusman R, Zeltser D, Rotstein R, et al. INFLAMET: an image analyzer to display erythrocyte adhesiveness/aggregation. Eur J Intern Med 2000;11:271-276.
23. Hershcovici T, Elishkewitch K, Rotstein R, et al. The erythrocyte adhesiveness/aggregation test to reveal real-time information of rheological relevance in patients with familial and primary hypercholesterolemia before and following plasma exchange. Ther Apheresis 2002;6:140-144.
24. Lidor A, Arber N, Berliner S, et al. Possible role for a plasma factor in the induction and/or maintenance of the state of leukocyte adhesiveness/aggregation in the peripheral blood. A study of mothers and their newborns. Scand J Clin Lab Invest 1991;51: 481-487.
25. Mchedlishvili G, Gobejishvili L, Mamaladze A, Momtselidze N, Varazashvili M. Microcirculatory stasis induced by hemorheological disorders: further evidence. Microcirculation 1999;6:97-106.
26. Yodice PC, Astiz ME, Kurian BM, Lin RY, Rackow EC. Neutrophil rheologic changes in septic shock. Am J Respir Crit Care Med 1997;155:38-42.
27. Lowe GD, Rumley A, Woodward M, Vessey M. C-reactive protein, idiopathic venous thromboembolism and hormone replacement therapy. Thromb Haemost 2000;84:730-731.
28. Lefer DJ. Statins as potent anti-inflammatory drugs. Circulation 2002;106:2041-2042.
29. Lowe G, Rumley A, Norrie J, et al. Blood theology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study. Thromb Haemost 2000;84: 553-558.
30. Kofoed SC, Wittrup HH, Sillesen H, Nordestgaard BG. Fibrinogen predicts ischaemic stroke and advanced atherosclerosis but not echolucent, rupture-prone carotid plaques: the Copenhagen City Heart Study. Eur Heart J 2003;24:567-576.
31. Schechner V, Shapira I, Berliner S, et al. Significant dominance of fibrinogen over immunoglobulins, C-reactive protein, cholesterol and triglycerides in maintaining increased red blood cell adhesiveness/aggregation: A model in hypercholesterotemic patients. Eur J Clin Invest 2003;33:955-961.
32. Ben-Ami R, Barshtein G, Mardi T, et al. A synergistic effect of albumin and fibrinogen on immunoglobulin-induced red blood cell aggregation. Am J Physiol Heart Circ Physiol 2003;285: H2663-H2669.